Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product

Acta Neurologica Scandinavica
T P Sabroe, A Sabers

Abstract

This report describes the laboratory and physical manifestations of lamotrigine-like toxicity in a young man with refractory epilepsy receiving lamotrigine presenting as anticonvulsant hypersensitivity syndrome (AHS) associated with an abrupt change of drug product.

References

Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Jun 16, 1999·The Annals of Pharmacotherapy·E MylonakisS Rounds
Dec 28, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S R KnowlesN H Shear
Jun 7, 2005·Expert Opinion on Drug Safety·Nithya J GogtayNilima A Kshirsagar
Apr 18, 2007·Neurology·K LiowUNKNOWN American Academy of Neurology
Aug 12, 2008·Current Drug Safety·Norberto KrivoyManuela G Neuman

❮ Previous
Next ❯

Citations

Mar 14, 2009·The Neurologist·Juan Gómez-AlonsoAntonio Gil-Nagel
Jul 26, 2010·Pharmaceuticals·Jong Woo Lee, Barbara Dworetzky
Jul 26, 2015·Clinical Neurology and Neurosurgery·Xiang-Qing WangSen-Yang Lang
Dec 1, 2010·CNS Neuroscience & Therapeutics·Julie Eve DesmaraisHoward C Margolese
May 20, 2011·The American Journal of Medicine·Patrice CacoubJean Claude Roujeau
Jul 2, 2009·Current Opinion in Allergy and Clinical Immunology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.